Pan-Cancer Markers for Proteomic Phenotyping

Exclusive 15% Discount on over 300 Primary Antibodies

Up to 35% Discount with PrecisA Monoclonals Bulk Order

Pan-Cancer Markers Validated on Human Cancers

Pan-cancer markers contribute to the development of universal diagnostic strategies, allowing for the identification of common genetic mutations across diverse cancers, such as the detection of shared pathways implicated in tumorigenesis.

Offering over 300 primary antibodies validated on human cancer tissue and cells, we aim to support proteomic studies, complementing genomics, and unveiling additional insights into pathways and processes driving human cancer biology.

With validation on human cancers and numerous cancer cell lines (data available on the Human Protein Atlas portal), our primary antibodies offer comprehensive coverage and enhanced validation for reliable results. Their versatility extends to multiple applications, ensuring they meet the diverse needs of your research projects.

👉 Exclusive 15% Discount Campaign

To further support your research, we're excited to announce a 15% discount on our Pan-Cancer antibodies. This special offer is available until August 31st, providing you with an excellent opportunity to enhance your proteomic phenotyping studies at a reduced cost.

Explore Pan-Cancer Markers in our webshop and unlock discounted prices at checkout!

Get Your Antibody Now

Upcoming Webinar "A Preclinical Systematic Exploration of Tumor Cell Vulnerabilities"

Don't miss out to gain valuable insights on:
• Preclinical models for drug development and target validation
• Personalized therapy beyond mutation analysis
• Additivity vs synergy
• A functional genomics approach to target glioblastoma invasion

Why Proteomic Matters?

Genomic and transcriptomic analyses, while comprehensive, may not fully capture the intricate complexity of cancer. Proteins, serving as the effectors of genomic functions, play a crucial role in orchestrating intricate molecular processes within cells.

Thus, integrating proteomic studies with genomics and transcriptomics introduces a novel paradigm, enabling the elucidation of hidden and undetected facets of human cancer biology.

Join us in unlocking the potential of proteomic phenotyping in cancer research. Together, let's advance our understanding of cancer biology and contribute to the development of targeted therapies. Explore our extensive antibody catalog and take advantage of our limited-time discount campaign.